Brexit, the EU and gene editing: does the UK have an advantage?

Written by Tristan Free (Digital Editor)

UK regulations on CRISPR engineered crops and livestock are changing: what do these changes mean for researchers? On the eve of Brexit, many researchers feared for the future of science in the UK. The possibility of withdrawn funding opportunities from such entities as the €85 billion Horizon Europe project; concerns over tariffs on lab equipment and legal disputes over clinical trials; and the security of European staff in a sector rife with free-flowing international travel of academics from one nation to another, all combined to create a major sense of uncertainty. Ultimately, the doomsday scenario was largely avoided: lab materials...

To view this content, please register now for access

Join our member community for FREE to access a collection of journal and online-only features, including:

  • Exclusive access to educational videos, eBooks and insights into top BioTechniques journal articles
  • The latest news and journal updates delivered straight to your inbox when you want it
  • Personalized recommendations for the latest member-exclusive podcasts, interviews and expert opinions
  • Priority registration to webinars, panel discussions and events
  • Access to competitions and journal publication discounts, including 10% off open access fees when you sign up today!